3 Simple Ways to Invest Like George Soros
George Budwell, The Motley Fool - Motley Fool - Sat Aug 30, 10:42AM CDT
Source: Wikimedia commons Before investing a single penny, you should have some type of overarching strategy or philosophy as a guide. Most commonly, the average investor turns to Warren Buffett in the hope of cracking Wall Street's secret code....
Regeneron Pharmaceuticals' Pipeline Progress Raises Costs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 29, 5:30PM CDT
Regeneron (REGN) expects adjusted SG&A costs to rise further in the remaining quarters of 2014.
Pfizer's C. Difficile Vaccine Gets Fast Track Status - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 29, 5:10PM CDT
Pfizer Inc. (PFE) announced that its vaccine candidate for clostridium difficile infection has been granted fast track designation by the FDA.
Final Glance: Biotechnology companies
AP - Fri Aug 29, 5:07PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading:
Intellipharmaceutics' Oxycodone Program to Prevent Overdose - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 29, 4:10PM CDT
Intellipharmaceutics (IPCI) upgraded its Rexista oxycodone development program.
Protalix/Pfizer's Elelyso Approved in Pediatric Patients - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 29, 4:00PM CDT
Protalix (PLX) and Pfizer (PFE) announced that the FDA has approved Elelyso injection for pediatric patients suffering from type I Gaucher disease.
Isis Pharmaceuticals Starts Phase III Study on ISIS-APOCIIIRx - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 29, 3:55PM CDT
Isis Pharmaceuticals, Inc. (ISIS) has initiated a phase III study which will evaluate the use of ISIS-APOCIIIRx.
Momenta-Sandoz's Generic Copaxone Accepted for Review by FDA - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 29, 2:20PM CDT
Momenta Pharmaceuticals (MNTA) announced that the FDA has accepted Sandoz's abbreviated new drug application for generic Copaxone for review.
Midday Glance: Biotechnology companies
AP - Fri Aug 29, 12:19PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
4 Biotechs That Might Be Bought Soon
at Investor's Business Daily - Fri Aug 29, 10:53AM CDT
The recent announcement that Roche (RHHBY) will buy InterMune (ITMN) for $8.3 billion brought new life to M&A speculation in the biotech industry, which had been relatively neglected as the buzz focused on tax-inversion deals by biopharmaceutical...
Early Glance: Biotechnology companies
AP - Fri Aug 29, 9:31AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
Protalix BioTherapeutics, Inc. (PLX) Jumps: Stock Adds 8.3% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Aug 29, 8:11AM CDT
Protalix BioTherapeutics, Inc. (PLX) was a big mover last session, as the company saw its shares rise by over 8% on the day.
Why Gilead Sciences (GILD) Could Be Positioned for a Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Aug 29, 7:53AM CDT
Positive earnings estimate revisions suggest that analysts are becoming more optimistic on Gilead Sciences’s earnings for the coming quarter and year.
OncoMed Pharmaceuticals (OMED) in Focus: Stock Up 9.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Aug 29, 7:51AM CDT
OncoMed Pharmaceuticals, Inc. (OMED) was a big mover last session, as its shares rose nearly 10% on the day.
Has Gilead Sciences, Inc.'s Star Drug Already Peaked?
Brian Orelli, The Motley Fool - Motley Fool - Thu Aug 28, 7:00PM CDT
Gilead Sciences ' hepatitis C drug scored $3.5 billion in sales in the second quarter, but prescriptions have been falling since before the quarter closed. First, new prescriptions started to fall in March. And then, as you'd expect, total...
Bristol-Myers' Oral HCV Treatment Daklinza Gets EU Clearance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 28, 5:50PM CDT
Bristol-Myers' (BMY) Daklinza has been cleared in the EU.
RedHill Expands ERADICATE Study on RHB-105 for H. pylori - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 28, 5:40PM CDT
RedHill Biopharma Ltd. (RDHL) recently provided an update on the ongoing phase III study ERADICATE Hp, on pipeline candidate RHB-105 for Helicobacter pylori infection (H. pylori).
Amgen's Chronic Heart Failure Drug Gets Priority Review - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 28, 5:20PM CDT
Amgen Inc. (AMGN) received encouraging news from the FDA as the regulatory body granted priority review status to the New Drug Application (NDA) for its pipeline candidate, ivabradine.
Most active Nasdaq-traded stocks
AP - Thu Aug 28, 5:02PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading: